Clinical Cancer Research Meeting Calendar Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malik, S. N.
Right arrow Articles by Kreisberg, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malik, S. N.
Right arrow Articles by Kreisberg, J. I.
Clinical Cancer Research Vol. 8, 1168-1171, April 2002
© 2002 American Association for Cancer Research

Molecular Oncology, Markers, Clinical Correlates

Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer1

Shazli N. Malik, Michael Brattain, Paramita M. Ghosh, Dean A. Troyer, Thomas Prihoda, Roble Bedolla and Jeffrey I. Kreisberg2

Departments of Surgery [S. N. M., P. M. G., R. B., J. I. K.] and Pathology [D. A. T., T. P.], University of Texas Health Science Center, San Antonio, Texas 78229; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263 [M. B.]; and South Texas Veterans Health Care System, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78229 [J. I. K.]

Purpose: Whereas the early stage of prostate cancer is marked by excessive proliferation, in advanced stages of the disease, a decreased apoptotic death rate (increased cell survival) also contributes to net tumor growth. Altered regulation of the mitogen-activated protein kinase (MAPK)-regulated cell proliferation and Akt-regulated cell survival pathways are suspected causes. In this study, we wanted to determine: (a) whether the degree of Akt activation can be assessed by immunohistochemical staining of paraffin- embedded human prostate cancer biopsies with an antibody to phospho-Akt (Ser473); and (b) whether phospho-MAPK/Erk1/2 and phospho-Akt expression are altered in prostate cancer.

Experimental design: To examine the activation status of MAPK/Erk1/2 and Akt, archival paraffin-embedded sections from 74 cases of resected prostate cancer were immunostained with antibodies to phospho-MAPK/Erk1/2 (Thr202/ Tyr204) and phospho-Akt (Ser473).

Results: The staining intensity for phospho-Akt was significantly greater in Gleason grades 8–10 (92% of such cases staining strongly) compared with prostatic intraepithelial neoplasia and all other grades of prostate cancer (only 10% of these cases staining strongly; P <= 0.001). The staining intensity for phospho-MAPK/Erk, on the other hand, was significantly greater for normal, hyperplastic, and prostatic intraepithelial neoplasia lesions but declined with disease progression, reaching its lowest level of expression in high Gleason grades 8–10 (P < 0.0001).

Conclusion: The activation state of the cell survival protein Akt can be analyzed in human prostate cancer by immunohistochemical staining of paraffin-embedded tissue with a phospho-specific Akt (Ser473) antibody. Advanced disease is accompanied by activation of Akt and inactivation of Erk.




This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
J. Bodo, L. Durkin, and E. D. Hsi
Quantitative In Situ Detection of Phosphoproteins in Fixed Tissues Using Quantum Dot Technology
J. Histochem. Cytochem., July 1, 2009; 57(7): 701 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Shukla-Dave, H. Hricak, N. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo
Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles
Clin. Cancer Res., June 1, 2009; 15(11): 3842 - 3849.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Shukla-Dave, H. Hricak, N. M. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo
Correlation of MR Imaging and MR Spectroscopic Imaging Findings with Ki-67, Phospho-Akt, and Androgen Receptor Expression in Prostate Cancer
Radiology, March 1, 2009; 250(3): 803 - 812.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
R. Kumar, S. Srinivasan, S. Koduru, P. Pahari, J. Rohr, N. Kyprianou, and C. Damodaran
Psoralidin, an Herbal Molecule, Inhibits Phosphatidylinositol 3-Kinase-Mediated Akt Signaling in Androgen-Independent Prostate Cancer Cells
Cancer Prevention Research, March 1, 2009; 2(3): 234 - 243.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
P. A Dennis
Targeting Akt in Cancer: Promise, Progress, and Potential Pitfalls
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 25 - 35.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Zhang, M.-T. Ling, Q. Wang, C.-K. Lau, S. C. L. Leung, T. K. Lee, A. L. M. Cheung, Y.-C. Wong, and X. Wang
Identification of a Novel Inhibitor of Differentiation-1 (ID-1) Binding Partner, Caveolin-1, and Its Role in Epithelial-Mesenchymal Transition and Resistance to Apoptosis in Prostate Cancer Cells
J. Biol. Chem., November 16, 2007; 282(46): 33284 - 33294.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
C. Festuccia, G. L. Gravina, P. Muzi, R. Pomante, L. Ventura, R. L Vessella, C. Vicentini, and M. Bologna
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer
Endocr. Relat. Cancer, September 1, 2007; 14(3): 601 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. A. Crowell, V. E. Steele, and J. R. Fay
Targeting the AKT protein kinase for cancer chemoprevention
Mol. Cancer Ther., August 1, 2007; 6(8): 2139 - 2148.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Shen and C. Abate-Shen
Pten Inactivation and the Emergence of Androgen-Independent Prostate Cancer
Cancer Res., July 15, 2007; 67(14): 6535 - 6538.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Bedolla, T. J. Prihoda, J. I. Kreisberg, S. N. Malik, N. K. Krishnegowda, D. A. Troyer, and P. M. Ghosh
Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation
Clin. Cancer Res., July 1, 2007; 13(13): 3860 - 3867.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. P. Kumar, S. Bhaskaran, M. Ganapathy, K. Crosby, M. D. Davis, P. Kochunov, J. Schoolfield, I-T. Yeh, D. A. Troyer, and R. Ghosh
Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract
Clin. Cancer Res., May 1, 2007; 13(9): 2784 - 2794.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Li, X. Wang, N. Li, J. Qiu, Y. Zhang, and X. Cao
hPEBP4 Resists TRAIL-induced Apoptosis of Human Prostate Cancer Cells by Activating Akt and Deactivating ERK1/2 Pathways
J. Biol. Chem., February 16, 2007; 282(7): 4943 - 4950.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. G. Fakih, D. L. Trump, J. R. Muindi, J. D. Black, R. J. Bernardi, P. J. Creaven, J. Schwartz, M. G. Brattain, A. Hutson, R. French, et al.
A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors
Clin. Cancer Res., February 15, 2007; 13(4): 1216 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. Foster, J. Black, C. LeVea, T. Khoury, B. Kuvshinoff, M. Javle, and J. F. Gibbs
COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of Survival
Ann. Surg. Oncol., February 1, 2007; 14(2): 752 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Gao, X. Ouyang, W. A. Banach-Petrosky, W. L. Gerald, M. M. Shen, and C. Abate-Shen
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
PNAS, September 26, 2006; 103(39): 14477 - 14482.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Moro, A. A. Arbini, E. Marra, and M. Greco
Up-regulation of Skp2 after Prostate Cancer Cell Adhesion to Basement Membranes Results in BRCA2 Degradation and Cell Proliferation
J. Biol. Chem., August 4, 2006; 281(31): 22100 - 22107.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. S. Chadha, T. Khoury, J. Yu, J. D. Black, J. F. Gibbs, B. W. Kuvshinoff, D. Tan, M. G. Brattain, and M. M. Javle
Activated Akt and Erk Expression and Survival After Surgery in Pancreatic Carcinoma
Ann. Surg. Oncol., July 1, 2006; 13(7): 933 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. A. Gomez, A. de las Pozas, and C. Perez-Stable
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Mol. Cancer Ther., May 1, 2006; 5(5): 1216 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Tsurutani, J. Fukuoka, H. Tsurutani, J. H. Shih, S. M. Hewitt, W. D. Travis, J. Jen, and P. A. Dennis
Evaluation of Two Phosphorylation Sites Improves the Prognostic Significance of Akt Activation in Non-Small-Cell Lung Cancer Tumors
J. Clin. Oncol., January 10, 2006; 24(2): 306 - 314.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J Lim, J-H Kim, J-Y Paeng, M-J Kim, S-D Hong, J-I Lee, and S-P Hong
Prognostic value of activated Akt expression in oral squamous cell carcinoma
J. Clin. Pathol., November 1, 2005; 58(11): 1199 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Yang, S. Xie, Md. S. Jamaluddin, S. Altuwaijri, J. Ni, E. Kim, Y.-T. Chen, Y.-C. Hu, L. Wang, K.-H. Chuang, et al.
Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells
J. Biol. Chem., September 30, 2005; 280(39): 33558 - 33565.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. Galanis, J. C. Buckner, M. J. Maurer, J. I. Kreisberg, K. Ballman, J. Boni, J. M. Peralba, R. B. Jenkins, S. R. Dakhil, R. F. Morton, et al.
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
J. Clin. Oncol., August 10, 2005; 23(23): 5294 - 5304.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Fassnacht, D. Weismann, S. Ebert, P. Adam, M. Zink, F. Beuschlein, S. Hahner, and B. Allolio
AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4366 - 4370.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Yang, M.-W. Chen, S. Terry, F. Vacherot, D. K. Chopin, D. L. Bemis, J. Kitajewski, M. C. Benson, Y. Guo, and R. Buttyan
A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer Cells
Cancer Res., June 15, 2005; 65(12): 5263 - 5271.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Moro, A. A. Arbini, E. Marra, and M. Greco
Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation
J. Biol. Chem., June 10, 2005; 280(23): 22482 - 22491.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Shah, W. A. Swain, D. Richardson, J. Edwards, D. J. Stewart, C. M. Richardson, D. E.B. Swinson, D. Patel, J. L. Jones, and K. J. O'Byrne
Phospho-Akt Expression Is Associated with a Favorable Outcome in Non-Small Cell Lung Cancer
Clin. Cancer Res., April 15, 2005; 11(8): 2930 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P. M Ghosh, S. N Malik, R. G Bedolla, Y. Wang, M. Mikhailova, T. J Prihoda, D. A Troyer, and J. I Kreisberg
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation
Endocr. Relat. Cancer, March 1, 2005; 12(1): 119 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
R. L. Lynch, B. W. Konicek, A. M. McNulty, K. R. Hanna, J. E. Lewis, B. L. Neubauer, and J. R. Graff
The Progression of LNCaP Human Prostate Cancer Cells to Androgen Independence Involves Decreased FOXO3a Expression and Reduced p27KIP1 Promoter Transactivation
Mol. Cancer Res., March 1, 2005; 3(3): 163 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. DeFeo-Jones, S. F. Barnett, S. Fu, P. J. Hancock, K. M. Haskell, K. R. Leander, E. McAvoy, R. G. Robinson, M. E. Duggan, C. W. Lindsley, et al.
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members
Mol. Cancer Ther., February 1, 2005; 4(2): 271 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. V. Thomas, S. Horvath, B. L. Smith, K. Crosby, L. A. Lebel, M. Schrage, J. Said, J. De Kernion, R. E. Reiter, and C. L. Sawyers
Antibody-Based Profiling of the Phosphoinositide 3-Kinase Pathway in Clinical Prostate Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8351 - 8356.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Bandyopadhyay, S. K. Pai, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, Y. Takano, K. Saito, T. Commes, D. Piquemal, et al.
PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer
Cancer Res., November 1, 2004; 64(21): 7655 - 7660.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. J. Assikis, K.-A. Do, S. Wen, X. Wang, J. H. Cho-Vega, S. Brisbay, R. Lopez, C. J. Logothetis, P. Troncoso, C. N. Papandreou, et al.
Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential
Clin. Cancer Res., October 15, 2004; 10(20): 6770 - 6778.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. David, J. Jett, H. LeBeau, G. Dy, J. Hughes, M. Friedman, and A. R. Brody
Phospho-Akt Overexpression in Non-Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage
Clin. Cancer Res., October 15, 2004; 10(20): 6865 - 6871.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. F. Stern
More than a Marker... Phosphorylated Akt in Prostate Carcinoma
Clin. Cancer Res., October 1, 2004; 10(19): 6407 - 6410.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Ayala, T. Thompson, G. Yang, A. Frolov, R. Li, P. Scardino, M. Ohori, T. Wheeler, and W. Harper
High Levels of Phosphorylated Form of Akt-1 in Prostate Cancer and Non-Neoplastic Prostate Tissues Are Strong Predictors of Biochemical Recurrence
Clin. Cancer Res., October 1, 2004; 10(19): 6572 - 6578.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. R. Uzgare and J. T. Isaacs
Enhanced Redundancy in Akt and Mitogen-activated Protein Kinase-induced Survival of Malignant versus Normal Prostate Epithelial Cells
Cancer Res., September 1, 2004; 64(17): 6190 - 6199.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. I. Kreisberg, S. N. Malik, T. J. Prihoda, R. G. Bedolla, D. A. Troyer, S. Kreisberg, and P. M. Ghosh
Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer
Cancer Res., August 1, 2004; 64(15): 5232 - 5236.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. R. Salas, J. Kim, F. Vakar-Lopez, A. L. Sabichi, P. Troncoso, G. Jenster, A. Kikuchi, S.-Y. Chen, L. Shemshedini, M. Suraokar, et al.
Glycogen Synthase Kinase-3{beta} Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity
J. Biol. Chem., April 30, 2004; 279(18): 19191 - 19200.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Jorgensen, R. Holm, G. M. Maelandsmo, and V. A. Florenes
Expression of Activated Extracellular Signal-Regulated Kinases 1/2 in Malignant Melanomas: Relationship with Clinical Outcome
Clin. Cancer Res., November 1, 2003; 9(14): 5325 - 5331.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Tanaka, M. V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M. G. Kazanietz
Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway
J. Biol. Chem., September 5, 2003; 278(36): 33753 - 33762.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Handra-Luca, H. Bilal, J.-C. Bertrand, and P. Fouret
Extra-Cellular Signal-Regulated ERK-1/ERK-2 Pathway Activation in Human Salivary Gland Mucoepidermoid Carcinoma: Association to Aggressive Tumor Behavior and Tumor Cell Proliferation
Am. J. Pathol., September 1, 2003; 163(3): 957 - 967.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. Grunwald and M. Hidalgo
Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment
J Natl Cancer Inst, June 18, 2003; 95(12): 851 - 867.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. K. Mellinghoff, C. Tran, and C. L. Sawyers
Growth Inhibitory Effects of the Dual ErbB1/ErbB2 Tyrosine Kinase Inhibitor PKI-166 on Human Prostate Cancer Xenografts
Cancer Res., September 15, 2002; 62(18): 5254 - 5259.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.